INJECTSENSE
A Serious Unmet Need -- with Significant Quality-of-Life Implications They live in a new era where they are constantly connected. They receive remote updates on almost all information critical to their lives and lifestyle, and they have the ability to monitor event status and to predict and plan for change. Yet in the medical field, a physician treating a progressive disease often has no choice but to be reactive -- often with harmful results. Critical data on patient disease state is collected... infrequently during sporadic office visits, yielding only a single data point to interpret past trends and assess long-term risk. Unlike their personal updates, continously available via sensors, GIS, and smart phone connectivity, there is no continuous stream of physiological measurement data from patients that can allow physicians to track and anticipate changes in disease status. The medical team cannot see how patient activity may be affecting disease indicators, and they can't see whether patients are even complying with drug therapy. The end result? More patient visits to the ER and doctor's office -- often when physiological damage has already been done. Injectsense: A New Paradigm for Therapy Management Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform. Their sensor, which can be delivered during a doctor's office visit, transforms the care model by enabling medical teams to track the disease at the pace of its evolution, whether months or years, receive early warning signs and provide preventive therapy. The configurable-on-demand sensor monitors patients 24/7, requires no patient lifestyle changes and reduces the need for medical office visits. More significantly, it allows physicians to establish an individual patient baseline for comparison, to receive data quickly at any time of day, to see histories and hourly dynamic disease state before irreversible damage is done, and to increase the effectiveness of drug therapy by tracking the effects of pharmaceuticals on key indicators over time.
INJECTSENSE
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
2014-05-12
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.injectsense.com
Total Employee:
11+
Status:
Active
Contact:
510-599-4800
Email Addresses:
[email protected]
Total Funding:
14.94 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Hemex Health
Hemex Health is a provider of a diagnostic device designed for populations at risk for malaria and sickle cell disease.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Current Employees Featured
Founder
Investors List
National Eye Institute
National Eye Institute investment in Grant - Injectsense
Leerink Revelation Partners
Leerink Revelation Partners investment in Series B - Injectsense
Official Site Inspections
http://www.injectsense.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Injectsense"
Injectsense | Implantable Sensors for Digital Health
Injectsense's ultra-miniature implantable sensors for digital health are self-anchoring platforms designed to continuously measure multiple parameters inside the body, including absolute …See details»
Company | Injectsense
Injectsense stands apart from other device developers thanks to its deep roots in two worlds: semiconductor and medical systems. We combine years of hands-on engineering experience …See details»
Injectsense - Crunchbase Company Profile & Funding
Injectsense may be growing as it has secured significant funding, which is a strong indicator of investor confidence and financial resources for expansion. The company and its sister …See details»
Injectsense, Inc. Company Profile | Emeryville, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Injectsense, Inc. of Emeryville, CA. Get the latest business insights from Dun & Bradstreet.See details»
Injectsense Inc. - LinkedIn
Injectsense Inc. | 664 followers on LinkedIn. Implantable Sensor-Enabled Digital Health | Injectsense: Improved Care Through Continuous Information Injectsense enables tracking of …See details»
Injectsense and Solid-State Microbattery | Injectsense
Injectsense is a sensor-enabled digital health company that enables tracking of progressive disease indicators and assessment of therapy effectiveness. The company's Silicon Valley …See details»
Injectsense - Contacts, Employees, Board Members, Advisors
Organization. Injectsense . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Contacts 6. ...See details»
Injectsense, Injectpower Secure $9.4 Million for Ultra-Mini …
Nov 15, 2023 EMERYVILLE, CA and GRENOBLE, France — Injectsense Inc., a sensor-enabled digital health company, and sister company Injectpower, a developer of ultra-miniature solid …See details»
Injectsense And Injectpower Secures $9.4 Million In Combined …
Dec 4, 2023 Injectsense - a sensor-enabled digital health company, and sister company Injectpower, a developer of ultra-miniature solid-state microbatteries for medical applications - …See details»
Injectsense Raises $9.4M for Ultra-Small Medical Implant Batteries
Nov 15, 2023 The study will allow Injectsense to finalize its product development under its quality system for ramp-up to clinical studies in 2025. The Injectsense board of medical …See details»
Injectsense and Solid-State Microbattery Partner Injectpower …
Nov 15, 2023 Injectsense received Series B funding in April 2019 and is expecting to close a Series C round in 2024. Injectsense currently has development revenue from a major non …See details»
Injectsense collects $1.7M grant for its eye implant smaller than a ...
Mar 17, 2022 Based on animal studies and in-vitro data, Injectsense was awarded a two-year small business innovation research (SBIR) grant of $1.7 million by the National Eye Institute in …See details»
How we built Injectsense and our Sensor Platform
Jul 19, 2023 Eight years ago, my parents were affected by glaucoma. My mother was prescribed topical drops but they stung her eyes, so she stopped taking them, and even omitted to tell the …See details»
Here's an Idea: Powerful Sensors for the Eye - Tech Briefs
Nov 29, 2023 InjectSense has invented an implantable sensor that detects direct dynamic pressure in the eye and transmits high-fidelity data from inside the eye of a patient to their …See details»
Injectsense Completes In Vivo Study for Long Term Intraocular …
Oct 15, 2019 Injectsense, a sensor-enabled digital health company, last week announced completion of a successful in-vivo animal study of the first implantable sensor and monitoring …See details»
Injectsense reports first human implantation of its IOP sensor
Aug 27, 2024 Researchers successfully completed the first human implantation of a remote IOP sensor manufactured by Injectsense, according to a press release from the company.The …See details»
FDA Breakthrough Designation | Injectsense
Injectsense Receives Breakthrough Device Program Designation from FDA, Highlights Eye Sensor Performance and Path to Human Studies EMERYVILLE, Calif., September 1, 2020 -- …See details»
Injectsense Completes First Human Implantation of its …
Aug 27, 2024 Injectsense received Series B funding in April 2019 and is expecting to close a Series C round in 2024. Injectsense currently has development revenue from a major non …See details»
Injectsense announces first human implant of ultraminiature IOP …
Aug 29, 2024 Digital health company Injectsense announced that it has successfully completed the first human implant and wireless IOP measurements using its ultraminiature implantable …See details»
Platform | Injectsense
The Injectsense sensor platform is highly versatile, permitting measurement of multiple physiological parameters including pressure, flow, oxygenation, and motion. As an advanced …See details»